How are children evaluated for suspected systemic lupus erythematosus (SLE)?

Evaluation of Children with Suspected SLE

Children with suspected SLE should undergo comprehensive laboratory assessment including ANA, anti-dsDNA antibodies, complement levels (C3, C4), complete blood count, comprehensive metabolic panel with creatinine, urinalysis with urine protein/creatinine ratio, and anti-phospholipid antibodies, combined with systematic organ-specific evaluation for renal, hematologic, mucocutaneous, and neuropsychiatric involvement 1.

Initial Laboratory Workup

The diagnostic evaluation centers on specific immunological markers and organ function assessment:

Core Immunological Testing

• ANA (Anti-nuclear antibodies): Positive in approximately 88% of pediatric SLE cases 2
• Anti-dsDNA antibodies: Elevated in 81% of children with SLE; correlates with disease activity and renal involvement 1, 2
• Anti-Ro/SSA, anti-La/SSB, and anti-RNP antibodies: Have prognostic value and anti-Ro/La antibodies are associated with neonatal lupus risk 1
• Complement levels (C3, C4): Sometimes associated with active disease, though not predictive of flares 1
• Anti-phospholipid antibodies: Associated with thrombotic manifestations, damage development, and pregnancy complications 1

Hematologic Assessment

Complete blood count is essential as:

• Anemia is the most common laboratory finding (69% of pediatric cases), variably associated with organ involvement and worse prognosis 1, 2
• Thrombocytopenia associates with renal disease progression and worse outcomes 1
• Severe leukopenia and lymphopenia (≤1×10⁹/L) correlate with increased infection risk 1

Renal Evaluation

Critical for prognosis, as renal involvement occurs in approximately 47% of children at presentation 2:

• Serum creatinine
• Urinalysis with microscopy
• Urine protein/creatinine ratio
• Blood pressure measurement

These parameters have predictive value for kidney involvement presence, outcome, and flare occurrence 1.

Additional Laboratory Tests

• Serum albumin: Provides information on renal involvement and prognosis 1
• Total IgG and subclass levels (IgG3 ≤60 μg/ml or IgG4 ≤20 μg/ml): Associated with increased infection risk, particularly in patients who may require immunosuppressive therapy 1
• C-reactive protein (CRP): Rarely elevated in SLE; significant elevation (>50 mg/L) should prompt evaluation for superimposed infection 1

Clinical Assessment by Organ System

Mucocutaneous Evaluation

• Examine for LE-specific lesions (acute, subacute, chronic, or intermittent cutaneous LE) and non-specific lesions 1
• Skin biopsy may be required when diagnosis is difficult, as many conditions mimic lupus 1
• Consider dermatology consultation for complex cutaneous manifestations

Musculoskeletal Assessment

• Arthritis is present in 56% of children at presentation 2
• Document joint involvement pattern and severity

Neuropsychiatric Screening

• Assess for headache, mood disorders, seizures, and cognitive impairment (memory, attention, concentration, word-finding difficulties) 1
• Clinical history is the primary monitoring tool, as no specific validated instrument exists for routine practice 1

Cardiovascular Considerations

• Blood pressure monitoring (essential for renal involvement assessment)
• Consider cardiovascular risk factor screening given long-term implications

Common Clinical Presentations in Children

Recognize these key patterns 2, 3:

• Prolonged fever (84% of cases) - most common non-specific symptom
• Pallor (41%)
• Arthralgia/arthritis (56%)
• Renal involvement (47%)
• Female predominance (87.5%, F:M ratio 7:1)
• Mean age at diagnosis: 11.3 years in females, 9.4 years in males

Critical Pitfalls to Avoid

1. Do not treat based solely on anti-dsDNA positivity without clinical activity 1
2. Do not overlook infection when CRP is significantly elevated, even with active SLE 1
3. Do not delay renal assessment - kidney disease may recur without symptoms 1
4. Consider non-Caucasian ethnicity as a risk factor - SLE is more common in these populations 4

Classification Criteria Application

While classification criteria (ACR-1997, SLICC-2012, ACR/EULAR-2019) are research tools, they inform diagnosis:

• SLICC-2012 demonstrates 98% sensitivity in pediatric populations but is not the most cost-effective 5
• ACR-1997 remains most cost-effective in specialized settings 5
• Expert consensus diagnosis remains the gold standard 5

Timing and Referral

Immediate rheumatology referral is warranted when multisystem involvement is suspected, particularly with:

• Positive ANA with compatible clinical features
• Renal involvement (proteinuria, hematuria, elevated creatinine)
• Cytopenias
• Neuropsychiatric symptoms
• Combination of fever, arthritis, and rash in at-risk populations

The evaluation must be systematic and comprehensive, as children with SLE are frequently very ill at presentation and require meticulous assessment to determine organ involvement severity 3.